Skip to main content
OpenTrials
Completed

NCT Number: NCT01432392

Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

The purpose of this study is to evaluate the impact of gastroesophageal reflux disease (GERD) treatment in primary care setting on symptom control and daily life in symptomatic GERD patients, using both GERD questionnaire and clinical symptoms assessment

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gastroesophageal Reflux Disease Deglutition Disorders Digestive System Diseases Esophageal Diseases Esophageal Motility Disorders Gastroesophageal Reflux Gastrointestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sofia, Bulgaria

Loading trial locations.

About this study

A prospective, observational study to describe symptom control and impact on daily life in patients with gastroesophageal reflux disease (GERD)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients known or newly diagnosed with GERD
  • Patients with typical GERD symptoms as heartburn and regurgitation for ≥2 days in the previous week
  • Patients, currently not treated with a proton pump inhibitor

Exclusion criteria

  • Patients who have been receiving treatment with non-steroidal antiinflammatory drugs within two weeks prior the inclusion in the study
  • Patients with medical history of surgery of the esophagus, stomach or duodenum
  • Pregnant or nursing females

Treatment and study plan

Primary outcomes

  1. Percent change in intensity and frequency for each of typical GERD symptoms from baseline to week 4-6

    Time frame: Day 0 to week 4-6

  2. Changes in GERD questionnaire(GERD-Q) scores from baseline to week 4-6

    Time frame: Day 0 to week 4-6

Secondary outcomes

  1. To evaluate the correlation between GERD-Q scores and symptom scores

    Time frame: two times

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Prospective, Observational Study to Describe Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease (GERD)

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Sep 13, 2011
Registry last updated
May 10, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.